Sanofi India Limited Cash Flow Conversion Efficiency

Latest as of December 2025: 0.585x

Sanofi India Limited cash flow conversion efficiency. Based on the latest financial reports, Sanofi India Limited (SANOFI) has a cash flow conversion efficiency ratio of 0.585x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs4.38 Billion ≈ $47.40 Million USD) by net assets (Rs7.49 Billion ≈ $81.02 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Sanofi India Limited (2004–2025)

Cash flow conversion efficiency of Sanofi India Limited from 2004 to 2025. This chart illustrates how Sanofi India Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Sanofi India Limited (SANOFI) share price today for real-time trading data and today's change.

Sanofi India Limited Cash Flow Conversion Ratio Explained

Sanofi India Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Sanofi India Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sanofi India Limited ranked by their cash flow conversion efficiency. Also see SANOFI market cap overview for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
SK Networks Co Ltd
KO:001740
-0.189x
Sparekassen Sjaelland-Fyn A/S
CO:SPKSJF
0.107x
Clinica Baviera
MC:CBAV
0.146x
Yutong Optical
SHE:300790
0.026x
Corsair Gaming Inc
NASDAQ:CRSR
0.045x
Silence Therapeutics PLC
NASDAQ:SLN
0.039x
Clairvest Group Inc.
TO:CVG
0.032x
Radius Recycling, Inc.
NASDAQ:RDUS
0.006x

Annual Cash Flow Conversion Efficiency for Sanofi India Limited (2004–2025)

The table below shows the annual cash flow conversion efficiency of Sanofi India Limited from 2004 to 2025. Review how much free cash does Sanofi India Limited generate to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Rs7.49 Billion
≈ $81.02 Million
Rs4.51 Billion
≈ $48.76 Million
0.602x +12.23%
2024-12-31 Rs8.61 Billion
≈ $93.07 Million
Rs4.62 Billion
≈ $49.91 Million
0.536x +136.29%
2023-12-31 Rs10.15 Billion
≈ $109.79 Million
Rs2.30 Billion
≈ $24.92 Million
0.227x -27.38%
2022-12-31 Rs12.76 Billion
≈ $137.97 Million
Rs3.99 Billion
≈ $43.12 Million
0.313x +24.47%
2021-12-31 Rs22.26 Billion
≈ $240.69 Million
Rs5.59 Billion
≈ $60.43 Million
0.251x -12.94%
2020-12-31 Rs21.19 Billion
≈ $229.16 Million
Rs6.11 Billion
≈ $66.09 Million
0.288x +70.83%
2019-12-31 Rs24.42 Billion
≈ $264.13 Million
Rs4.12 Billion
≈ $44.59 Million
0.169x +0.20%
2018-12-31 Rs22.19 Billion
≈ $240.00 Million
Rs3.74 Billion
≈ $40.44 Million
0.168x -21.53%
2017-12-31 Rs20.26 Billion
≈ $219.15 Million
Rs4.35 Billion
≈ $47.05 Million
0.215x +15.52%
2016-12-31 Rs17.36 Billion
≈ $187.70 Million
Rs3.23 Billion
≈ $34.89 Million
0.186x +41.87%
2015-12-31 Rs16.27 Billion
≈ $175.97 Million
Rs2.13 Billion
≈ $23.05 Million
0.131x -26.53%
2014-12-31 Rs14.86 Billion
≈ $160.69 Million
Rs2.65 Billion
≈ $28.65 Million
0.178x -11.89%
2013-12-31 Rs13.47 Billion
≈ $145.64 Million
Rs2.73 Billion
≈ $29.48 Million
0.202x -14.90%
2012-12-31 Rs12.04 Billion
≈ $130.22 Million
Rs2.86 Billion
≈ $30.97 Million
0.238x +29.53%
2011-12-31 Rs11.17 Billion
≈ $120.76 Million
Rs2.05 Billion
≈ $22.17 Million
0.184x +42.45%
2010-12-31 Rs10.14 Billion
≈ $109.68 Million
Rs1.31 Billion
≈ $14.14 Million
0.129x -12.71%
2009-12-31 Rs9.32 Billion
≈ $100.77 Million
Rs1.38 Billion
≈ $14.88 Million
0.148x +2.28%
2008-12-31 Rs8.29 Billion
≈ $89.66 Million
Rs1.20 Billion
≈ $12.95 Million
0.144x -1.97%
2007-12-31 Rs7.07 Billion
≈ $76.44 Million
Rs1.04 Billion
≈ $11.26 Million
0.147x -27.73%
2006-12-31 Rs6.08 Billion
≈ $65.78 Million
Rs1.24 Billion
≈ $13.40 Million
0.204x -32.31%
2005-12-31 Rs5.24 Billion
≈ $56.65 Million
Rs1.58 Billion
≈ $17.05 Million
0.301x +77.53%
2004-12-31 Rs4.22 Billion
≈ $45.62 Million
Rs715.33 Million
≈ $7.74 Million
0.170x --

About Sanofi India Limited

NSE:SANOFI India Drug Manufacturers - General
Market Cap
$842.25 Million
Rs77.88 Billion INR
Market Cap Rank
#9298 Global
#463 in India
Share Price
Rs3381.60
Change (1 day)
+0.95%
52-Week Range
Rs2772.80 - Rs4746.40
All Time High
Rs10072.65
About

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company offers pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, anti-infectives, and central nervous system under the Lantus, Toujeo, Soliqua, Clexane, Amaryl, Cardace, Lasix, Lasilactone, Glimepiride, Cetapin, Targocid, Frisium, Targoci… Read more